20 October 2017
News and Views
Links and Services
A study in this month's Gastroenterology assesses ledipasvir and sofosbuvir plus ribavirin for treatment of HCV infection in patients with advanced liver disease.
There are no effective and safe treatments for chronic hepatitis C virus (HCV) infection of patie
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors